Clover Health Investments's revenue for the
three
months ended in Mar. 2024 was €319 Mil.
Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €1,713 Mil.
Clover Health Investments's Revenue per Share for the
three
months ended in Mar. 2024 was €0.56.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €3.45.
Warning Sign:
Clover Health Investments Corp revenue per share is in decline over the past 12 months.
During the past 5 years, Clover Health Investments's highest 3-Year average Revenue per Share Growth Rate was 85.50% per year. The lowest was 36.30% per year. And the median was 60.90% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Clover Health Investments's Revenue
For the Healthcare Plans subindustry, Clover Health Investments's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clover Health Investments's Revenue Distribution in the Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Clover Health Investments's Revenue distribution charts can be found below:
* The bar in red indicates where Clover Health Investments's Revenue falls into.
Clover Health Investments Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,713 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clover Health Investments (STU:7QD) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Clover Health Investments Revenue Related Terms
Thank you for viewing the detailed overview of Clover Health Investments's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Clover Health Investments (STU:7QD) Business Description
Clover Health Investments Corp is a healthcare technology company. It uses its proprietary technology platform to collect, structure, & analyze health & behavioral data to improve medical outcomes & lower costs for patients. The Group has two operating segments. The insurance segment provides PPO(Preferred provider Organization) & HMO(Health Maintenance Organization) plans to Medicare Advantage members in several states & seeks to improve care & lower costs which generally provide access to a wide network of primary care providers, specialists, & hospitals. Non-insurance segment includes the Company's operations relating to CMS' DC (Direct Contracting) Model, which provides options aimed at reducing expenditures & preserving or enhancing the quality of care for beneficiaries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:7QD has been successfully added to your 